MedPath

DILANTIN-30 SUSPENSION

DILANTIN-30 SUSPENSION

Approved
DIN Number

00023442

Drug Class

Human

Market Date

Dec 31, 1968

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00023442
AIG Number0101372002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AB02 PHENYTOIN
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:12.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

PHENYTOINActive
Strength: 30 MG / 5 ML
Monograph: PHENYTOIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.